EGFR and neoplasm: Thus, we hypothesized that immediate EGFR-TKI combination after 24 h PEM exposure might arrest tumor cells not yet entering S-phase at G1-phase, thereby attenuating late-phase effects and losing synergistic efficacy (Figure 1D), while a 48 h PEM exposure achieves a late-phase inhibition rate comparable to that of continuous PEM exposure.